Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers

A Placebo-Controlled, Combined Single and Multiple Rising Dose Study to Determine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SLV338 After Intravenous Administration in Healthy Male Subjects

This study will investigate the safety and tolerability of the first IV dosing of SLV338 in healthy volunteers.

Inclusion Criteria:

• healthy

Exclusion Criteria:

• not healthy